易方达标普生物科技美元现汇C(012867)
动态评分： 6.13分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2021-12-31 | BHVN | Biohaven Pharmaceutical Holding Co Ltd | 152.79 | 1.01% |
| 2021-12-31 | TPTX | Turning Point Therapeutics Inc | 132.78 | 0.88% |
| 2021-12-31 | BCRX | BioCryst Pharmaceuticals Inc | 131.44 | 0.87% |
| 2021-12-31 | FATE | Fate Therapeutics Inc | 131.61 | 0.87% |
| 2021-12-31 | HALO | 奥洛兹美医疗 | 128.88 | 0.85% |
| 2021-12-31 | KYMR | Kymera Therapeutics Inc | 127.51 | 0.84% |
| 2021-12-31 | TGTX | TG Therapeutics Inc | 126.78 | 0.84% |
| 2021-12-31 | UTHR | 联合治疗 | 126.74 | 0.84% |
| 2021-12-31 | ISEE | IVERIC bio Inc | 126.09 | 0.83% |
| 2021-12-31 | APLS | Apellis Pharmaceuticals Inc | 124.83 | 0.82% |
| 2021-12-31 | FOLD | 爱美医疗 | 124.22 | 0.82% |
| 2021-12-31 | INCY | 因塞特医疗 | 124.11 | 0.82% |
| 2021-12-31 | PRTA | Prothena Corp plc | 124.38 | 0.82% |
| 2021-12-31 | AGIO | Agios Pharmaceuticals Inc | 122.87 | 0.81% |
| 2021-12-31 | BLUE | 蓝鸟生物 | 123.27 | 0.81% |
| 2021-12-31 | EXEL | 伊克力西斯 | 120.79 | 0.8% |
| 2021-12-31 | SAGE | Sage Therapeutics Inc | 121.15 | 0.8% |
| 2021-12-31 | CCXI | ChemoCentryx Inc | 119.44 | 0.79% |
| 2021-12-31 | EBS | Emergent BioSolutions Inc | 120.01 | 0.79% |
| 2021-12-31 | MRTX | Mirati Therapeutics Inc | 120.37 | 0.79% |
公告&资料
